Literature DB >> 14963288

Transient ischemic attacks before ischemic stroke: preconditioning the human brain? A multicenter magnetic resonance imaging study.

Susanne Wegener1, Barbara Gottschalk, Verica Jovanovic, René Knab, Jochen B Fiebach, Peter D Schellinger, Thomas Kucinski, Gerhard J Jungehülsing, Peter Brunecker, Bianca Müller, Anna Banasik, Nicola Amberger, Klaus D Wernecke, Mario Siebler, Joachim Röther, Arno Villringer, Markus Weih.   

Abstract

BACKGROUND AND
PURPOSE: We investigated whether transient ischemic attacks (TIAs) before stroke can induce tolerance by raising the threshold of tissue vulnerability in the human brain.
METHODS: Sixty-five patients with first-ever ischemic territorial stroke received diffusion- and perfusion-weighted MRI within 12 hours of symptom onset. Epidemiological and clinical data, lesion volumes in T2, apparent diffusion coefficient (ADC) maps and perfusion maps, and cerebral blood flow and cerebral blood volume values were compared between patients with and without a prodromal TIA.
RESULTS: Despite similar size and severity of the perfusion deficit, initial diffusion lesions tended to be smaller and final infarct volumes were significantly reduced (final T2: 9.1 [interquartile range, 19.7] versus 36.5 [91.2] mL; P=0.014) in patients with a history of TIA (n=16). This was associated with milder clinical deficits.
CONCLUSIONS: The beneficial effect of TIAs on lesion size in ADC and T2 suggests the existence of endogenous neuroprotection in the human brain.

Entities:  

Mesh:

Year:  2004        PMID: 14963288     DOI: 10.1161/01.STR.0000115767.17923.6A

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  101 in total

1.  Induction of ischemic tolerance protects the retina from diabetic retinopathy.

Authors:  Diego C Fernandez; Pablo H Sande; Mónica S Chianelli; Hernán J Aldana Marcos; Ruth E Rosenstein
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

Review 2.  14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia.

Authors:  Yan Dong; Rui Zhao; Xiao Qian Chen; Albert Cheung Hoi Yu
Journal:  Mol Neurobiol       Date:  2010-05-14       Impact factor: 5.590

Review 3.  Evolving concepts regarding transient ischemic attacks.

Authors:  Bernardo Liberato; Shyam Prabhakaran; Ralph L Sacco
Journal:  Curr Atheroscler Rep       Date:  2005-07       Impact factor: 5.113

Review 4.  Preconditioning and tolerance against cerebral ischaemia: from experimental strategies to clinical use.

Authors:  Ulrich Dirnagl; Kyra Becker; Andreas Meisel
Journal:  Lancet Neurol       Date:  2009-04       Impact factor: 44.182

Review 5.  Preconditioning and its clinical potential.

Authors:  P Magill; T Murphy; D J Bouchier-Hayes; K J Mulhall
Journal:  Ir J Med Sci       Date:  2009-03-21       Impact factor: 1.568

Review 6.  Poised for success: implementation of sound conditioning strategies to promote endogenous protective responses to stroke in patients.

Authors:  Bethann McLaughlin; Jeff M Gidday
Journal:  Transl Stroke Res       Date:  2013-01-11       Impact factor: 6.829

Review 7.  Clinical application of preconditioning and postconditioning to achieve neuroprotection.

Authors:  Cameron Dezfulian; Matthew Garrett; Nestor R Gonzalez
Journal:  Transl Stroke Res       Date:  2012-11-15       Impact factor: 6.829

Review 8.  Neuroimmune Response in Ischemic Preconditioning.

Authors:  Ashley McDonough; Jonathan R Weinstein
Journal:  Neurotherapeutics       Date:  2016-10       Impact factor: 7.620

9.  Should the STAIR criteria be modified for preconditioning studies?

Authors:  Michael M Wang; Guohua Xi; Richard F Keep
Journal:  Transl Stroke Res       Date:  2013-02       Impact factor: 6.829

10.  3-Nitropropionic acid-induced ischemia tolerance in the rat brain is mediated by reduced metabolic activity and cerebral blood flow.

Authors:  Oliver Bracko; Valentina Di Pietro; Giacomo Lazzarino; Angela M Amorini; Barbara Tavazzi; Judith Artmann; Eric C Wong; Richard B Buxton; Michael Weller; Andreas R Luft; Susanne Wegener
Journal:  J Cereb Blood Flow Metab       Date:  2014-06-18       Impact factor: 6.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.